Gene Therapy Ready Site Network

Join more than 1,000 research sites who use Advarra as their IBC of record. Advarra complies with NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) and can provide support for research and clinical trials involving:

• Recombinant DNA
• Synthetic nucleic acid molecules
• mRNA engineered vaccines
• Genetic engineering/gene therapy
• Infectious microorganisms
• Hazardous biological materials
• Non-clinical plant and animal research

To learn more about Advarra, visit their Clinical Leader page.